Recent Patents on Melanoma with Focus on Genetic Strategies

Author(s): Talia Gramiccia, Rosita Saraceno, Alessandro D. Stefani, Sergio Chimenti, Alessandro Di Stefani

Journal Name: Recent Patents on Anti-Infective Drug Discovery

Volume 3 , Issue 2 , 2008

Become EABM
Become Reviewer


Recent advances in molecular biology have enhanced the understanding of the pathology of melanocytic lesions. Several targetable pathways, responsible for survival and apoptosis resistance in melanoma cells, have been described and current research has focused on mechanism inactivating these pathways. However, the therapeutic resistance of malignant melanoma remains the main limit that cast the poor prognosis of cutaneous melanoma. Current advances in high-resolution genome-wide technologies, as well as gene-specific mutational analysis, in conjunction with genetic and phenotypic analyses, improved animal models, may ultimately help to better define the seminal molecular events contributing to disease pathogenesis and ultimately identify more effective therapeutic targets. The focus of this review is to summarize the emerging patents in the treatment and diagnosis of melanoma related to the latest genetic models and bio-molecular discoveries.

Keywords: Melanoma, melanoma genetics, melanoma biology, targeted therapy

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [136 - 144]
Pages: 9
DOI: 10.2174/157489108784746632
Price: $65

Article Metrics

PDF: 2